VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE...

18
VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA

Transcript of VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE...

Page 1: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

VA Quality Measurement: Is There a “Halo Effect?”

Steven M.Asch MD MPH

VA Sepulveda HSR&D COE

RAND Health

Geffen School of Medicine at UCLA

Page 2: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

VA Performance Measurement

• Dates back to 1995• ~30 mostly chart-based process measures,

varying evidence support• Facility-based primary care sampling• Feedback, public reporting• Regional managers have financial

incentives

Page 3: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

VA Improves 12/13 Leading Indicators 1995- 2000

0

10

2030

4050

6070

8090

100

Hgba1c Flu vac CRC Screen ASA MI

19951996199819992000

Jha NEJM 348:22 2003

Page 4: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

VA Beats Medicare 12-1 in 2000

01020

3040

5060

708090

100

Mammo Pneumovac DM eye

MedicareVA

Jha NEJM 348:22 2003

Page 5: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

What About Overall Quality?

• Leading indicator systems – Focus QI efforts, but– Vulnerable to gaming, resource

misallocation

• What about overall quality? • How does VA overall quality

compare to the community?

Page 6: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Overall Process Quality Measured by QATools

• Literature reviews conducted to develop evidence-explicit indicators

• 5 Delphi expert panels convened to evaluate recommended indicators

• 348 clinically detailed process indicators for 26 clinical areas

• Example: Patients with pre-existing coronary disease with an LDL > 130mg/dl should begin diet or drug therapy within 3 months.

Page 7: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Example Clinical Areas General Medical Conditions

• BPH (4)• Depression (14)• Diabetes (13)• Dyspepsia/PUD (8)• Headache (21)• Low back pain (6)• Orthopedic conditions (10)• Preventive care (35)• STDs (26)

Oncologic Conditions • Colorectal cancer (12)• CA pain and palliation (3)• Prostate cancer (6)

Cardiopulmonary Conditions• Asthma (25)• Congestive heart failure (36)• COPD (20)• Coronary artery disease (37)• Hyperlipidemia (7)• Hypertension (26)• Pneumonia (5)• Stroke/TIA (10)

Page 8: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Study Sites

•SEATTLE

ORANGE COUNTY

PHOENIX

LITTLE ROCK

INDIANAPOLIS

• CLEVELAND•

GREENVILLE

MIAMI•

NEWARK•

• BOSTON

• SYRACUSE

• • •

LANSING•

VISN 22

VISN 11

Page 9: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

% Receiving Indicated Care

53

67*

58

73*

44

64*

5653

0

10

20

30

40

50

60

70

80

Overall Chronic Prev Acute

CommVA

Page 10: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

% Receiving Indicated Care

5969

63

81*

52

68*

0

10

20

30

40

50

60

70

80

90

COPD HTN DM

CommVA

Page 11: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Is There A “Halo Effect?”

• Does the VA advantage exist only in specific processes subject to VA performance management?

• Does it extend to clinically related conditions or areas?

• Does it extend to clinically unrelated areas?

P. Gaugin-”Self Portrait with a Halo”

Page 12: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

3 Mutually Exclusive Summary Scores

In VA measurement set (26 indicators) Not in VA measurement set, but in same

condition (178 indicators) Neither (167 indicators)

Page 13: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Adjusted % Receiving Indicated Care

53

67*

42

69*

58

71*

51 54

0

10

20

30

40

50

60

70

80

Overall VAConditions

Comm

VA

VAMeasures

Neither

Page 14: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Conclusions

• VA is improving on leading indicators

• VA beats Medicare on leading indicators

• VA beats community on broader measures

• “Halo effect” of performance measurement diminishes with clinical distance

Page 15: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Wins: Performance measurement

Losses: ?????

Ties: Acute care, eye exams, COPD

Errors: Hoping for too big a halo

Page 16: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Questions

Page 17: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Adjusted RR of Indicated Care

1.22*

2.04*

2.74*

0.00

0.25

0.50

0.75

1.00

1.25

1.50

1.75

2.00

VA PerformanceMeasures

VA PerformanceMeasure Conditions

Non-VA PerformanceMeasure Conditions

Page 18: VA Quality Measurement: Is There a “Halo Effect?” Steven M.Asch MD MPH VA Sepulveda HSR&D COE RAND Health Geffen School of Medicine at UCLA.

Sampling: Men>35 with 2 Visits/yr

Community VA

Source Random digit dial

Admin data

Response rate 48% 97%

N 992 597

Study period 1/98-12/99 1/98-12/99

Sites 12 cities 26 facilities